Editorial Department


Head of Unit, Managing Editor - Beata Kreiner

Deputy Editor in Chief - dr. Katarzyna Fijał


Publishing the Pharmacological Reports


The Pharmacological Reports (ISSN: 1734-1140; e-ISSN: 2299-5684) publishes science articles dealing with experimental and clinical pharmacology. It features original papers, reviews, and occasional abstracts from international congresses and symposiums. The journal publishes research results in the field of broadly defined pharmacology covering behavioral, biochemical, molecular and cellular investigations aimed at expanding the knowledge on mechanisms of drugs action and potential therapeutic agents. The thematic profile of the articles is focused mainly on the research involving the dysfunction of the central nervous system, among others, depression, schizophrenia, anxiety disorders, neurodegenerative diseases – conditions that represent the most serious challenges tackled by modern societies in highly-developed countries. Editors are especially concerned with ensuring high quality of published manuscripts through promoting research involving the application of state-of-the-art methods, including, among others, the use of transgenic animals, optogenetics, transcriptomics, proteomics or modern imaging techniques.

The journal is issued bimonthly. The articles are published in English.

Maintaining the high-quality journal content is ensured by the Editor in Chief assisted by the Advisory Board consisting of leading specialists, including foreign researchers, who actively promote the journal and support its development, participate in discussions on the journal’s policy, share their scientific experience as well as knowledge in the particular field by reviewing papers. The Advisory Board is notified of the current journal’s quality and impact by means of annual reports produced by the Publisher.
The Editor in Chief is supported by the Associate Editors selected from among experienced researchers, and experts in their field of science. The initial, content-related selection of submitted papers by persons with adequate competencies, within the scope of topics addressed in the journal, translates directly into the quality of published manuscripts and shortens the time necessary for preliminary assessment and taking decisions on eventual submission for external reviews.


Editorial Board:

Editor in Chief: Małgorzata Filip
Deputy Editor in Chief: Katarzyna Fijał
Managing Editor: Beata Kreiner
Associate Editors: Marta Baranowska-Kuczko, Dasiel O. Borroto-Escuela, Władysława Daniel, Ali Husein Eid, Luca Ferraro, Jakub Fichna, Arie Lev Gruzman, Danuta Jantas, Michał Korostyński, Grzegorz Kreiner, Katarzyna Miękus, Stefan Mordalski, Christian Mueller, Agnieszka Nikiforuk, Rafał Olszanecki, Joanna Pera, Elżbieta Salińska, Maciej Suski, Halina Waś, Barbara Zabłocka, Magdalena Zielińska


From 2014 until the end of 2019 the Pharmacological Reports was published in cooperation with Elsevier. Currently, a publishing agreement was concluded with a new publisher – Springer Nature – that on 1st January 2020 accepted full liability towards the journal.

The editorial process is based on an electronic system for editing and publishing the journal. All files uploaded into the system undergo anti-virus as well as anti-plagiarism control. The time necessary for publishing papers and providing online access to the journal content has been reduced to a minimum.

The Pharmacological Reports is sold and distributed in an electronic version using modern international platforms dedicated to scientific, technical and medical topics (ScienceDirect and Springer Nature). Currently, the journal has limited circulation. Only advance and deposit copies are printed.

The Pharmacological Reports is indexed in the most prestigious database, that is the Web of Science, and listed in the JCR (Journal Citation Reports) with a journal impact factor reaching the value of 3.919 in 2021 (the five-year impact factor – 3.472). The journal is ranked in the second quartile (Q2) by JCR.

According to the latest list of scientific journals and reviewed materials from international conferences, which were published in 2021 by the Ministry of Education and Science, the Pharmacological Reports received 100 points.

The papers published in the journal are cited in all most important databases: BIOSIS, Biological Abstracts, CNKI, Chemical Abstracts Service (CAS), Current Contents/Clinical Medicine, Dimensions, EBSCO Discovery Service, EMBASE, Google Scholar, Institute of Scientific and Technical Information of China, Journal Citation Reports/Science Edition, Medline, Naver, OCLC WorldCat Discovery Service, ProQuest‑ExLibris Primo, ProQuest‑ExLibris Summon, SCImago, SCOPUS, Science Citation Index Expanded (SciSearch), TD Net Discovery Service, UGC‑CARE List (India).

The new website can be accessed via the following link: https://www.springer.com/journal/43440. Past issues of the journal are also available at: https://www.sciencedirect.com/journal/pharmacological-reports and http://if-pan.krakow.pl/pl/pharmacological-reports/.

In 2019 the Institute received funds for 2019-2020, from the financial sources of the Ministry of Science and Higher Education allocated to activities aimed at popularizing science, for co-financing the project titled: “Increasing the impact and visibility of the Pharmacological Reports among international research society and R&D sector”. The most important tasks undertaken within the scope of the project include, among others: maintaining the upward trend for the impact factor (JCR); building a platform for exchanging information between researchers and R&D sector through establishing cooperation with renowned researchers and experienced leaders in R&D, aimed at publishing articles dealing with the latest research trends and the most significant achievements in the pharmacological sector concerning the implementation of the basic research results; improving the graphic design of the review articles and promoting the journal in social media, Internet and at scientific conferences.
The implementation of the project was extended until 30 June 2021.